NCT05755308View on ClinicalTrials.gov

Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis

NANot yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2026

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
PROCEDURE

Autologous FMT

Autologous faecal microbiota transplantation by colonoscopy.

PROCEDURE

Placebo FMT

Placebo FMT will consist of 250 mL water. Placebo infusions will be delivered by colonoscopy.

Trial Locations (1)

00168

Fondazione Policlinico Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05755308 - Faecal Microbiota Transplantation to Ameliorate Nintedanib-induced Diarrhea in Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter